Kedar Datar, MBA Boehringer-Ingelheim

Kedar Datar is currently an Associate Director, CMC Project leader within the Bio Business Unit at the Boehringer Ingelheim Fremont facility. There he leads Drug Substance manufacturing operations from all aspects of CMC development.

Previously, he worked as an Associate Director of Pharmaceutical Development at Santen Inc., an ophthalmology focused pharamaceutical company, where he lead a small molecule program from Phase III onwards, managing all aspects of manufacturing, stability, validation, LCM and launch readiness. During his stint with Santen, he was focused on developing solutions to deliver low volume doses using a Pre-filled syringe.

Prior to Santen, Kedar held the positions of Project Manager at a CMO, and an Associate Scientist at a start up in Southern California.

Kedar has a MS in Bioengineering from Clemson University, SC and an MBA from the Rady School of Management at UC, San Diego.